PNC Financial Services Group’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $104K | Buy |
8,951
+3,801
| +74% | +$44K | ﹤0.01% | 2688 |
|
|
2025
Q1 | $45K | Buy |
5,150
+3,119
| +154% | +$27.2K | ﹤0.01% | 3161 |
|
|
2024
Q4 | $29.2K | Sell |
2,031
-193
| -9% | -$2.77K | ﹤0.01% | 3366 |
|
|
2024
Q3 | $50.2K | Buy |
2,224
+537
| +32% | +$12.1K | ﹤0.01% | 3088 |
|
|
2024
Q2 | $32.8K | Buy |
1,687
+144
| +9% | +$2.8K | ﹤0.01% | 3245 |
|
|
2024
Q1 | $57.9K | Buy |
1,543
+167
| +12% | +$6.27K | ﹤0.01% | 2923 |
|
|
2023
Q4 | $77K | Buy |
1,376
+72
| +6% | +$4.03K | ﹤0.01% | 2750 |
|
|
2023
Q3 | $53.8K | Buy |
1,304
+5
| +0.4% | +$206 | ﹤0.01% | 2927 |
|
|
2023
Q2 | $72.5K | Buy |
1,299
+197
| +18% | +$11K | ﹤0.01% | 2830 |
|
|
2023
Q1 | $61.5K | Sell |
1,102
-322
| -23% | -$18K | ﹤0.01% | 2866 |
|
|
2022
Q4 | $51.9K | Sell |
1,424
-768
| -35% | -$28K | ﹤0.01% | 2963 |
|
|
2022
Q3 | $62K | Buy |
2,192
+354
| +19% | +$10K | ﹤0.01% | 2836 |
|
|
2022
Q2 | $83K | Sell |
1,838
-208
| -10% | -$9.39K | ﹤0.01% | 2690 |
|
|
2022
Q1 | $155K | Buy |
2,046
+1,761
| +618% | +$133K | ﹤0.01% | 2428 |
|
|
2021
Q4 | $41K | Buy |
285
+118
| +71% | +$17K | ﹤0.01% | 3224 |
|
|
2021
Q3 | $23K | Sell |
167
-65
| -28% | -$8.95K | ﹤0.01% | 3447 |
|
|
2021
Q2 | $46K | Buy |
232
+9
| +4% | +$1.78K | ﹤0.01% | 3117 |
|
|
2021
Q1 | $41K | Buy |
223
+39
| +21% | +$7.17K | ﹤0.01% | 3098 |
|
|
2020
Q4 | $25K | Buy |
184
+123
| +202% | +$16.7K | ﹤0.01% | 3248 |
|
|
2020
Q3 | $7K | Buy |
61
+12
| +24% | +$1.38K | ﹤0.01% | 3612 |
|
|
2020
Q2 | $4K | Buy |
+49
| New | +$4K | ﹤0.01% | 3691 |
|